title: Maintenance infliximab infusions forever?
authors.affiliation: University of Washington, Seattle, USA.
authors.forename: Scott D
authors.initials: SD
authors.lastname: Lee
authors.forename: Christina M
authors.initials: CM
authors.lastname: Surawicz
mesh_terms: D000208:Acute Disease; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects; D003424:Crohn Disease / Q000188:drug therapy*; D004334:Drug Administration Schedule; D005765:Gastrointestinal Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012074:Remission Induction; D013997:Time Factors; D016896:Treatment Outcome; D014376:Tuberculosis / Q000139:chemically induced
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab